
Hercules Capital (HTGC) Stock Forecast & Price Target
Hercules Capital (HTGC) Analyst Ratings
Bulls say
Hercules Capital is a specialty finance company with a positive outlook due to its solid credit quality, increase in originations, and relatively low exposure to software and AI companies compared to other BDC peers. With a strong focus on life sciences and first-lien investments, the company has strong potential for growth and a defensive posture in a volatile market. The company's core EPS is in line with peers, and its funding activity has been favorable due to current market conditions.
Bears say
Hercules Capital is a specialty finance company that focuses on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. While the company reports solid net investment income and maintains a strong credit quality, their elevated exposure to the software sector (30%+) and potential risks from AI disruption may cause difficulties with loan maturities and equity rounds. Additionally, given the current macro uncertainty and volatility, the stock's near-term returns will likely be driven by the dividend rather than share appreciation. Therefore, it may be wise to take a neutral stance on the stock, with a decreased price target based on their NAV estimate and potential risks from their software exposure.
This aggregate rating is based on analysts' research of Hercules Capital and is not a guaranteed prediction by Public.com or investment advice.
Hercules Capital (HTGC) Analyst Forecast & Price Prediction
Start investing in Hercules Capital (HTGC)
Order type
Buy in
Order amount
Est. shares
0 shares